[Peritonitis: dual treatment strategy of operation and antibiotics].
D000328:Adult; D015377:Cilastatin / Q000191:economics / Q000627:therapeutic use; D000077728:Cilastatin, Imipenem Drug Combination; D003131:Combined Modality Therapy; D003362:Cost-Benefit Analysis; D003646:Debridement / Q000191:economics; D004338:Drug Combinations; D004359:Drug Therapy, Combination / Q000191:economics / Q000627:therapeutic use*; D006801:Humans; D015378:Imipenem / Q000191:economics / Q000627:therapeutic use; D008826:Microbial Sensitivity Tests; D010538:Peritonitis / Q000209:etiology / Q000401:mortality / Q000628:therapy*; D015996:Survival Rate; D016896:Treatment Outcome
D004338:Drug Combinations; D015377:Cilastatin; D015378:Imipenem; D000077728:Cilastatin, Imipenem Drug Combination